Dr. Jack Hoppin is the co-founder and chief executive officer of Invicro. Invicro, LLC was founded with the mission of improving the role and function of imaging in translational drug discovery and development across all therapeutic areas. Invicro’s multi-disciplinary team provides a full range of image informatics, engineering and operational services. Prior to co-founding Invicro in 2008, Dr. Hoppin served as the vice president of imaging systems at Bioscan, Inc. Dr. Hoppin, a thought-leader in the molecular imaging research and drug development community, brings 15+ years in experience in the design, development and commercialization of pre-clinical instrumentation, analytical software and imaging-based assays. As an active member of the imaging community, Dr. Hoppin recently serving on the World Molecular Imaging Society Board of Trustees. He is also a member of the Society of Nuclear Medicine CMIIT Industry Council and the Harvard Catalyst Faculty.
Dr. Hoppin earned his bachelor of science degree in mathematics with a minor in physics from the College of the Holy Cross in Worcester, Mass., USA, and his master of science degree and doctor of philosophy degree in applied mathematics from the University of Arizona in Tucson, Ariz., USA. Dr. Hoppin worked as an Alexander von Humboldt post-doctoral fellow in medical physics at the Research Center in Jülich, Germany.